 | Up a level |
Ellis, R, Tang, D, Nasr, B, Greenwood, A, McConnell, A, Anagnostou, ME, Elias, M, Verykiou, S, Bajwa, D, Ewen, T, Reynolds, NJ, Barrett, P, Carling, E, Watson, G, Armstrong, Jane, Allen, AJ, Horswell, S, Labus, M and Lovat, PE (2019) Epidermal AMBRA1 and Loricrin; a paradigm shift in the prognostication and stratification of AJCC stage I melanomas. British Journal of Dermatology, 182 (1). pp. 156-165. ISSN 1365-2133
Armstrong, Jane, Hill, DS, McKee, CS, Hernandez-Tiedra, S, Lorente, M, Lopez-Valero, I, Eleni Anagnostou, M, Babatunde, F, Corazzari, M, Redfern, CP, Velasco, G and Lovat, PE (2015) Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. Journal Of Investigative Dermatology, 135 (6). pp. 1629-1637. ISSN 0022-202X
O'Boyle, Graeme, Swidenbank, I, Marshall, H, Barker, CE, Armstrong, Jane, White, SA, Fricker, SP, Plummer, R, Wright, M and Lovat, PE (2013) Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070. British Journal of Cancer, 108. pp. 1634-1640. ISSN 0007-0920
Armstrong, Jane, Martin, S, Illingworth, N A, Jamieson, D, Neilson, A, Lovat, PE, Redfern, CPF and Veal, GJ (2011) The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide. Oncology Reports, 27. pp. 293-298. ISSN 1791-2431
Flockhart, R, Armstrong, Jane, Reynolds, NJ and Lovat, PE (2009) NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma. British Journal of Cancer, 101 (8). pp. 1448-1455. ISSN 0007-0920